Literature DB >> 6967906

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors.

M T Lotze, B R Line, D J Mathisen, S A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6967906

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  65 in total

1.  Confusion about the tissue distribution of lymphokine-activated killer (LAK) cells.

Authors:  A A Maghazachi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

Authors:  K F Yoong; D H Adams
Journal:  Clin Mol Pathol       Date:  1996-10

3.  Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

Authors:  P McCulloch; G Gallagher; L P Walsh; Y Zaloom; J Xie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

4.  [Growth factors. A new dimension in understanding oncogenesis].

Authors:  V Heinemann; U Jehn
Journal:  Klin Wochenschr       Date:  1985-08-16

Review 5.  IL-2: the first effective immunotherapy for human cancer.

Authors:  Steven A Rosenberg
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

Review 6.  Exploring the NK cell platform for cancer immunotherapy.

Authors:  Jacob A Myers; Jeffrey S Miller
Journal:  Nat Rev Clin Oncol       Date:  2020-09-15       Impact factor: 66.675

7.  Systemic trafficking of macrophages induced by bone cement particles in nude mice.

Authors:  Pei-Gen Ren; Sheen-Woo Lee; Sandip Biswal; Stuart B Goodman
Journal:  Biomaterials       Date:  2008-09-27       Impact factor: 12.479

Review 8.  Interleukin-2 and interferon in renal cell carcinoma.

Authors:  P Wersäll
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

9.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

10.  Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.

Authors:  I H Ames; G M Gagne; A M Garcia; P A John; G M Scatorchia; R H Tomar; J G McAfee
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.